Johnson & Johnson EBIT 2010-2024 | JNJ

Johnson & Johnson EBIT for the quarter ending September 30, 2024 was $3.823B, a 33.89% decline year-over-year.

  • Johnson & Johnson 2023 EBIT was 17.095B, a 15.06% decline from 2022.
  • Johnson & Johnson 2022 EBIT was 20.125B, a 3.66% increase from 2021.
  • Johnson & Johnson 2021 EBIT was 19.414B, a 15.5% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Johnson & Johnson EBIT 2010-2024 | JNJ

  • Johnson & Johnson 2023 EBIT was 17.095B, a 15.06% decline from 2022.
  • Johnson & Johnson 2022 EBIT was 20.125B, a 3.66% increase from 2021.
  • Johnson & Johnson 2021 EBIT was 19.414B, a 15.5% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B